e-health-digital-artificial intelligence-pharma (english)

FDA supporting digital transformation of healthcare.

Less than 50 algorithms were accredited by FDA in the 18 years starting 1995.In the last four years…...

Does data analytics influence your decision process?

If the answer is YES, then you could attempt this webinar.It´s just to remind you that our 4th Health…...

UK cost-effectiveness agency NICE has said that guided, self-help digital cognitive behavioural therapy (CBT) apps can be used by the NHS for initial treatment of children and young people with anxiety – at least while more information is gathered. New guidance from the health technology assessment (HTA) organisation covers four digital technologies that it says can help the five to 18 age group with mild to moderate symptoms of anxiety or low mood, once they are approved for use by NHS England under its Digital Technology Assessment Criteria (DTAC) framework. This is the first example of a green light being given under NICE's early value assessment (EVA) pathway for medtech innovations, which was piloted with five apps for mild anxiety last year and aims to provide quicker access to digital health products, diagnostics, and devices that could relieve pressure on the NHS. The process aims to take around six months, quicker than the current timescale for NICE medical technologies guidance. It comes amid recognition that the digital technologies route first piloted in 2019 has only seen one positive recommendation by NICE since it went live. The four apps that are covered by the guidance are as follows: BfB Labs' Lumi Nova: Tales of Courage, a digital therapeutic (DTx) in the form of a game for children aged seven to 12, which combined exposure therapy and psychoeducational content within an intergalactic role-playing game; Online Social anxiety Cognitive therapy for Adolescents (OSCA), an internet programme of cognitive therapy for social anxiety in adolescents aged 14 to 18 years old; Online support and intervention for child anxiety (OSI), an internet-based, parent-led, and therapist-supported psychological intervention for children aged five to 12 years old with symptoms of anxiety; SilverCloud's 'Space from' series, a CBT range which targets 15 to 18-year-olds with symptoms of anxiety, low mood, or both, with online support from therapists; Another app reviewed in the pilot – Healios' ThinkNinja CBT Bytesize – is awaiting CE mark approval, so cannot be used yet. "The availability of effective mental health treatments is limited, with a shortage of qualified staff and long waiting times," according to the guidance. "Many children and young people are not getting access to treatment when they need it [and these] technologies are a way to increase access to treatment with support from a healthcare professional." An initial assessment with a healthcare professional is needed before using these technologies to make sure they are suitable, and children and young people are then checked on a regular basis. NICE said it will be up to the local NHS to determine how they wish to commission these new treatment options once they are DTAC approved.

AVATAR MEDICAL, a spin-off company from Institut Curie and Institut Pasteur, is one of nine French companies out of more than 1,000 applications to be a winner of the EIC Accelerator, a selective innovation program that supports startups from the European Union.

This guide helps executives & marketing management in the pharmaceutical industry change course as needed to better the chances of recovery.

Find out in our new article how mHealth applications are changing the lives of many people and transforming the way pharmaceutical companies do research, development, and marketing.

The healthcare supply chain ensures the right medicines are available to patients when they need them. Can AI help revolutionize this complex process?

WaytoB have partnered with Trinity College to co-develop Digi-ID, an inclusive e-learning platform. WaytoB are the tech partner for Digi-ID which aims to address the challenge of digital inclusion and low usage of digital technologies amongst people with ID.

Background: The COVID-19 pandemic has driven most clinicians, from those practicing in small independent practices to those in large system, to adopt virtual care. However, individuals and organiza...

How Ogilvy Health and Doceree are reaching physicians with precision point-of-care messaging on telehealth platforms.

Clinical Trial Data Management Software Market: Introduction The global clinical trial data management software market is anticipated to reach ~US$ 7 Bn by 2030. The clinical trial data management software market is projected to expand at a CAGR of ~8% from 2020 to 2030, in terms of revenue.

The Darwin Club for Social Sciences holds its next public Webinar on Monday, 13th March at 14.00 UK time.The speaker will be Geoffrey Hodgson and his topic…...

Known for introducing innovative new health technologies to hospitals and healthcare facilities for the past 60 years across the island of Ireland, Hospital Services Limited (HSL) have expanded into the UK with the launch of their new headquarters in the East Midlands, England, with the £1.7m invest...

The ability to leverage a single, standardized data store such as Azure Health Data Services helps clinical teams make more informed care decisions and reduces the time spent on administrative tasks.

Check out this exciting webinar on Monday with my wonderful colleagues Natasha Ratcliffe and Maddi Needham discussing patient engagement in medtech!

Article: Solve 10 common pharma digital marketing challenges – reducing content costs, increasing marketing reach, improving eDetailing ROI, and more.

The pandemic poses an obvious threat to the face-to-face nature of sales reps, which, along with major congresses being cancelled, means the major routes pharmaceutical companies contact physicians has disappeared.

Noël Theodosiou, CEO and Sergio Corbo, COO of Luminous, reimagine a new healthcare model of “doctors without borders...The promise of telemedicine to reduce health inequities...

In March 2020 when the Coronavirus was registered in the country, the norm of Patients queuing up at health facilities changed as health workers and patients were all at risk of contracting the deadly disease.

21 Jul 2021
Novo Nordisk's Ozempic digital marketing in Australia can be exemplar for other players in type 2 diabetes space, says GlobalData

Posted in Pharma
...| July 21, 2021...

#Aimedis #AIMX #AIMXtoken #token #Blockchain #AimedisNFT #NFT #Non-Fungible-Tokens #ehealth #healthcare #IDO #mobility #tothemoon #tothestreets Medical research is a multi-billion business that is…...

The effects of COVID-19 have given a good shake to an already ever-changing marketing landscape, and for pharma marketers it is more difficult than ever to cut through the...